Christopher Barr

Christopher Barr is a Senior Policy Analyst at Health Canada, focusing on governance and bilateral agreements for the National Strategy for Drugs for Rare Diseases. With a robust background in the pharmaceutical industry and healthcare, Christopher has previously owned a consulting practice at Kelvinbridge Inc. and served as Director Strategist at Human Branding Inc., providing strategic leadership in qualitative research projects for pharmaceutical companies. Prior roles at sixsense strategy group included Senior Science & Strategy Consultant, where Christopher led strategy and medical communication projects for global clients. Additionally, Christopher has experience as a Hospital Pharmacist at Nuffield Health and as a Pharmacist Training Facilitator for NHS Education for Scotland, complemented by foundational roles in various pharmacy settings. Christopher holds a Master's degree in Pharmacy from the University of Strathclyde.